RichardJBramMDPhD
Pediatric Hematology & Oncology • Rochester, MNPediatric Coagulation Disorder Hematology, Pediatric Hematologic Oncology
Professor and Chair, Pediatric and Adolescent Medicine, Mayo Medical School
Dr. Bram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 1989 - 1993- Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1987 - 1989
Stanford University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1988 - Present
MN State Medical License 1998 - 2024
TN State Medical License 1994 - 1999- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2002
Clinical Trials
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors Start of enrollment: 2015 Jun 21
Publications & Presentations
PubMed
- 1 citationsAccelerated Aging in Cyclophilin B-Deficient Mice Downstream of p21-Cip1/Waf1.Ying Zhang, Robert J Pignolo, Richard J Bram> ;JBMR Plus. 2022 Oct 1
- Early expression of mature αβ TCR in CD4CD8T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.Kimberly G Laffey, Robert J Stiles, Melissa J Ludescher, Tessa R Davis, Shariq S Khwaja, Richard J Bram, Peter J Wettstein, Venkataraman Ramachandran, Christopher A Pa...> ;Proceedings of the National Academy of Sciences of the United States of America. 2022 Jul 5
- 13 citationsPhase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors.Matthew R Schuelke, Justin H Gundelach, Matt Coffey, Emma West, Karen Scott, Derek R Johnson, Adel Samson, Alan Melcher, Richard G Vile, Richard J Bram> ;Neuro-Oncology Advances. 2022 Jun 17
- Join now to see all
Press Mentions
A Golden Age for Pediatric CardiologyFebruary 2nd, 2017
Grant Support
- Cyclophilin B As A Therapeutic Target In GlioblastomaNational Institute Of Neurological Disorders And Stroke2011
- CAML In T Cell Development And FunctionNational Institute Of Allergy And Infectious Diseases2008–2011
- CAML In Normal And Oncogenic Functions Of The EGFRNational Cancer Institute2005–2009
- Calcium Modulating Cyclophilin Ligand In Normal &Oncogenic Functions Of The EGFRNational Cancer Institute2007–2008
- CAML In T Cell Development And FunctionNational Institute Of Allergy And Infectious Diseases2007
- Role Of TACI In B Cell Function And TransformationNational Cancer Institute2004–2007
- Role Of Cadml In Embryonic And Lymphocyte DevelopmentNational Cancer Institute2004
- Role Of TACI In B Cell Function And TransformationNational Cancer Institute2003
- Role Of Cadml In Embryonic And Lymphocyte DevelopmentNational Cancer Institute2000–2003
- TACI And B Cell Function And TransformationNational Cancer Institute1999–2002
- Core--Cell Microinjection Shared ResourceNational Cancer Institute1997–2002
- TACI And B Cell Function And TransformationNational Cancer Institute1998
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
